Download eBook for Free

FormatFile SizeNotes
PDF file 1.7 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.


Purchase Print Copy

 Format Price
Add to Cart Paperback52 pages $8.00

Traditionally, the cost of conducting cancer clinical trials has been supported by a combination of research sponsors, institutions, and third-party payers. However, health insurers and other payers are increasingly reluctant to reimburse for direct patient care provided as part of a clinical trial. These policies — driven in part by a perception that patients enrolled in trials incur substantial additional costs — might impede efforts to enroll patients in clinical trials. Yet there is little evidence regarding the costs of treating patients in clinical trials. Given the great importance of timely clinical research, there is thus an urgent need for unbiased information on the possible effects of participation in government-sponsored clinical trials on patient care costs. Such data would make any cost-sharing burden explicit and could lead to better mechanisms for financing clinical trials. This report documents the design and methods of the Cost of Cancer Treatment Study (CCTS), an ongoing effort to obtain precise and generalizable estimates of the direct care costs of patients who participate in National Cancer Institute-sponsored clinical cancer trials (see Using a retrospective design, the CCTS will sample multiple clinical trials and cancer providers around the country. Costs of treating patients in clinical trials at these providers will then be compared with a set of matched controls not in any trial, thereby yielding an estimate of the additional cost — if any — associated with clinical trial participation. Because of the large sample size and the recruitment of patients in both academic and community settings, the CCTS will provide precise and generalizable estimates of these costs.

The study was conducted within RAND Health.

This report is part of the RAND monograph report series. The monograph/report was a product of RAND from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.